Large-scale testing (Phase 3)Study completedNCT00943722
What this trial is testing
V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+3 more
Merck Sharp & Dohme LLC 3,074